EmpiraMed, Inc. — Maynard, Massachusetts

EmpiraMed, Inc. is a clinical research site located in Maynard, Massachusetts, United States 01754.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

EmpiraMed, Inc. has participated in 1 clinical trials.

Therapeutic areas: Anaplastic Lymphoma Kinase-positive, Carcinoma Non-small-cell Lung.

Sponsors: Takeda.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for EmpiraMed, Inc.?

EmpiraMed, Inc. has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has EmpiraMed, Inc. conducted?

EmpiraMed, Inc. has 1 clinical trials on record. Their work covers Anaplastic Lymphoma Kinase-positive, Carcinoma Non-small-cell Lung.

Is EmpiraMed, Inc. accredited by Crixeo Health?

EmpiraMed, Inc. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about EmpiraMed, Inc.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.